Denaturing gradient gel electrophoresis (DGGE) was used to probe for mutations associated with pyrazinamide (PZA) resistance in the pncA gene of Mycobacterium tuberculosis. DGGE scans for mutations across large regions of DNA and rivals sequencing in its ability to detect DNA alterations. Specific mutations can often be recognized by their characteristic denaturation pattern, which serves as a molecular fingerprint. Five PCR target fragments were designed to scan for DNA alterations across 600 bp of pncA in 181 M. tuberculosis isolates from patients residing in the U.S-Mexico border states of Texas and Tamaulipas, respectively. A region of pncA was observed with a high GC content and a melting temperature approaching 90°C that was initially refractory to denaturation, and a DGGE target fragment was specifically designed to detect mutations in this region. DGGE detected pncA mutations in 82 of 83 PZA-resistant isolates. By contrast, only 1 of 98 PZA-susceptible isolates harbored a detectable DNA alteration. The pncA gene was sequenced from 41 isolates, and 32 DNA alterations in 32 PZA-resistant isolates were identified, including 11 new mutations. DGGE also detected nine isolates whose susceptibility to PZA appeared to be incorrect, and DNA sequencing confirmed these apparent errors in drug susceptibility testing. These results demonstrate the power and usefulness of DGGE in detecting mutations associated with PZA resistance in M. tuberculosis.Pyrazinamide (PZA) is a front-line drug used in the treatment of tuberculosis (TB). In a typical short-course (6-month) therapy, PZA is administered with rifampin (RIF), isoniazid (INH), and ethambutol (EMB) for the first 2 months of treatment, followed by 4 months of treatment with INH and RIF (1). During the initial acute phase, PZA and RIF are responsible for much of the killing of persisting Mycobacterium tuberculosis bacteria (23, 48). The mode of action of PZA is complex and not fully understood. It requires activation to pyrazinoic acid by a pyrazinamidase/nicotinamidase (PZase) encoded by the pncA gene (48). The activated acid form is excreted and then reabsorbed in a protonated form. It is thought that the acidification of the M. tuberculosis cells by the protonated form represents the primary mechanism by which PZA kills tubercle bacilli (48, 49). PZase inactivation is the primary mechanism for developing resistance to PZA (31,35,47,48). Any mutation in pncA that inactivates the encoded enzyme appears to be sufficient to confer resistance. Consequently, PZA resistance mutations are highly diverse and are found throughout pncA. Cumulative reports indicate that between 72 and 98% of PZAresistant isolates harbor pncA mutations (33,46,49). More recent reports, however, tend to support the upper end of this range (48). Earlier reports may have been subject to inaccurate susceptibility testing using culture methods. Susceptibility testing media must have a pH of 6 for PZA to be active against susceptible cells, and this pH is near the limit for growth of tubercle bacill...